Guanwei Fan | Component-Based TCM | Best Researcher Award
Dr. Guanwei Fan, First Teaching Hospital of Tianjin University, China.
Dr. Guanwei Fan ๐งโ๐ฌ, Vice President of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine ๐ฅ, is a leading researcher in cardiovascular pharmacology using Traditional Chinese Medicine (TCM) ๐โค๏ธ. As Director of the Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation and Principal Investigator at the National Key Lab of Component-based TCM, he has led over 20 major national and international research projects ๐๐. Recognized globally ๐, he ranks in the top 2% of scientists worldwide and contributes significantly to TCM innovation, publishing over 160 papers and securing 25 patents ๐๐งช.
Publication Profiles
ย Education & Experienceย
-
๐ Ph.D. in Traditional Chinese Medicine โ Specialized in cardiovascular disease prevention and treatment
-
๐ฅ Vice President, First Teaching Hospital of Tianjin University of TCM
-
๐งช Director, Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation
-
๐งฌ Principal Investigator, National Key Laboratory of Component-based TCM (Cardiovascular Pharmacology Innovation Team)
-
๐ Participated in over 20 national and international research collaborations including 973 & Key R&D programs
-
๐งพ Filed 25 invention patents (10 granted), with 4 transferred to industry
-
๐ Published 160+ peer-reviewed papers; H-index: 43
Suitability for the Award
Dr. Guanwei Fan is an exemplary candidate for the Best Researcher Award, recognized for his transformative contributions to the field of Traditional Chinese Medicine (TCM), particularly in the prevention and treatment of cardiovascular diseases. As Vice President of the First Teaching Hospital of Tianjin University of TCM, Director of the Tianjin Key Laboratory of TCM Prescription and Syndrome Transformation, and Principal Investigator of the National Key Laboratory of Component-based TCMโCardiovascular Pharmacology Innovation Team, Dr. Fan leads multidisciplinary efforts that bridge traditional medicine with modern pharmacology.
ย Professional Development
Dr. Guanwei Fanโs career exemplifies leadership in integrating traditional Chinese medical theory with modern pharmacology ๐ง ๐ก. As a principal investigator and lab director, he continuously mentors researchers and leads cutting-edge projects focused on cardiovascular therapeutics through TCM ๐ฌโค๏ธ. His commitment to translational medicine bridges research and real-world application, demonstrated by multiple patent transfers to industry ๐ญ๐. Dr. Fanโs inclusion in the national “Ten Thousand Talents Program” and other elite scientific tracks marks him as a vital force in Chinaโs health innovation ecosystem ๐จ๐ณ๐. His work fosters international cooperation, further cementing his role as a global TCM ambassador ๐๐ฟ.
ย Research Focusย
Dr. Guanwei Fanโs research centers on cardiovascular disease prevention and treatment through the lens of Traditional Chinese Medicine (TCM) โค๏ธ๐ฟ. His work emphasizes component-based TCM, investigating multi-target pharmacology and syndrome transformation ๐๐. By leveraging modern biomedical techniques alongside traditional principles, he aims to decode TCM formulations and validate their efficacy through empirical science ๐งช๐. His team contributes to innovative drug development, targeting complex mechanisms in heart-related illnesses ๐ซ๐งฌ. This integrative approach not only enhances the credibility of TCM globally ๐๐ but also advances precision medicine with a holistic health perspective ๐งโโ๏ธ๐ฌ.
ย Awards & Honorsย
-
๐ Selected for the national “Ten Thousand Talents Program”
-
๐ผ State Council Special Government Allowance recipient
-
๐งโ๐ฌ MOST Leading Talent in Scientific and Technological Innovation
-
๐ฑ First Young Qi Huang Scholar
-
๐ First Tianjin Outstanding Young Scholar
-
๐จโโ๏ธ First Tianjin Medical Talent
-
๐ Youth Expert with Outstanding Contributions, Ministry of Human Resources
-
๐ Ranked in Top 2% of Global Scientists (2022โ2024)
-
๐ฅ 1 First-Class and ๐ฅ 3 Second-Class Science & Technology Progress Awards
-
๐ง Nominated for National Top 100 Excellent Doctoral Theses
-
๐๏ธ Received Tianjin Excellent Doctoral Thesis Award
Publication Top Noted
-
Lingguizhugan decoction inhibits pulmonary hypertension via IL-33/ST2-regulated macrophage IL-6 secretion (Phytomedicine, 2025) ๐ซ๐งฌ
-
Meta-analysis on Shenmai Injection for coronary heart disease and heart failure (Drug Evaluation Research, 2025) โค๏ธ๐
-
Th17 Cells in Cardiovascular Disease โ Review (2025) ๐ง ๐ซ
-
Role of macrophages in cardiac arrhythmias: pathogenesis and therapeutic perspectives โ Review (2025) โก๐งซ
-
Borneolum syntheticum metabolites reduce atherosclerosis by inhibiting macrophage foam-cell formation (Acta Pharmacologica Sinica, 2025) ๐งช๐ฉธ
-
Topical treatment of allergic contact dermatitis with Portulacae Herba via Nrf2/HO-1/NF-ฮบB pathway (Chinese Journal of Experimental Traditional Medical Formulae, 2025) ๐ฟ๐งด
-
Screening Uncaria-based natural inhibitors for Alzheimerโs using near-infrared fluorescence probe (Sensors and Actuators B: Chemical, 2025) ๐ง ๐ก
-
Isoprenaline induces cardiac hypertrophy by inhibiting LSD1 (Cardiovascular Toxicology, 2025) ๐โค๏ธโ๐ฅ